COVID-19 Diaphragm Weakness Persists 2 Years Later but Shows Improvement with Muscle Training

Medical News: Persistent Breathing Difficulties in Long COVID
A recent study by researchers from Germany and Italy shines a light on a pressing issue affecting many COVID-19 survivors even two years post-recovery: persistent breathing difficulties, often described as "exertional dyspnea." While lung and heart functions often appear normal in these individuals, a distinct problem with the diaphragm muscle has emerged as a potential cause. This Medical News report explores how diaphragm weakness might explain lingering symptoms and whether targeted muscle training could provide a solution.


COVID-19 Diaphragm Weakness Persists 2 Years Later but Shows Improvement with Muscle Training

The study, conducted by researchers at the University Hospital RWTH Aachen in Germany, Witten/Herdecke University, the Scuola Superiore Sant’Anna in Italy, and the Schoen Klinik in Germany, sought to unravel this link. By examining 30 individuals who had previously been hospitalized due to COVID-19, the team delved into the mechanics of this persistent breathlessness, sometimes debilitating for long COVID patients. The study highlights how diaphragm weakness may be involved and assesses the effectiveness of a specific therapy known as Inspiratory Muscle Training (IMT).
 
The Link Between Diaphragm Weakness and Long COVID Symptoms
The study primarily aimed to observe if diaphragm weakness continued over an extended period and if it was tied to exertional dyspnea, a common issue in long COVID. Additionally, researchers aimed to see if IMT could help these patients regain some normalcy by improving diaphragm function.
 
Testing conducted two years after COVID-19 infection revealed that over two-thirds of the 30 participants continued to experience significant exertional dyspnea. Further investigation using advanced diagnostic techniques confirmed that, indeed, diaphragm weakness persisted. This condition was accompanied by reduced cortical activation of the diaphragm, meaning the brain’s signal to activate the muscle was weakened. As a result, patients were left struggling with everyday activities that once felt effortless.
 
Trialing Inspiratory Muscle Training
A subset of participants (18 out of the 30) who had noticeable diaphragm muscle weakness was invited to participate in a randomized trial of Inspiratory Muscle Training. IMT involves breathing exercises designed to gradually strengthen the inspiratory muscles, particularly the diaphragm. The participants were split into two groups: one underwent a real IMT regimen, while the other performed “sham” IMT exercises that offered no real resistance or muscle challenge.
 
Over six weeks, the IMT group showed noteworthy progress. The diaphragm’s strength and endurance increased significantly, which translated into better performance on breathing tasks. Not only did the IMT participants see their diaphragm’s strength improve, but their inspiratory muscle fatigue also reduced, allowing them to exert themselves for longer periods without feeling out of breath. In contrast, the sham group showed no such improvements.
 
Key Findings and Implications
The study produced several key findings, underscoring the potential role of IMT in managing long COVID symptoms related to diaphragm weakness:
 
-Improved Muscle Strength and Fatigue Resistance: IMT significantly improved diaphragm strength, measured as sniff nasal inspiratory pressure and transdiaphragmatic pressure. Notably, participants in the IMT group also managed to extend the time they could exert themselves before reaching muscle fatigue, showcasing a tangible benefit of the training.
 
-Enhanced Diaphragm Activation: One of the most intriguing results was the increase in the diaphragm’s voluntary activation index (DVAI), which hints at better brain-muscle communication post-training. This increase was not observed in the sham group, suggesting that IMT might also boost the neural control of the diaphragm.
 
-Sustained Benefits: Follow-up assessments indicated that the benefits of IMT persisted for at least six weeks post-training, suggesting a lasting impact on the diaphragm's functionality and, consequently, on alleviating exertional dyspnea.
 
-Potential for Widespread Application: These findings imply that IMT could be a valuable therapeutic tool for long COVID patients experiencing similar issues, especially those who do not respond to conventional treatments targeting the lungs or heart.
 
Challenges and Future Directions
Although this study opens the door for new treatment possibilities, several questions remain. The trial’s small sample size and short duration of follow-up are limitations that researchers acknowledge. The durability of IMT’s benefits beyond six weeks is yet to be fully understood, and further studies involving larger cohorts and longer observation periods will be crucial.
 
Additionally, the study raised questions about whether other muscles involved in respiration, beyond the diaphragm, might benefit from IMT, as the breathing process involves a range of muscles working together. The researchers also noted that a rigorous approach is essential for successful IMT, requiring strict supervision and progressively increased resistance over time to yield the observed results.
 
Why Standard Tests May Fall Short
An interesting aspect of this research is the observation that standard lung function tests may not capture issues with diaphragm weakness. This could mean that many individuals with long COVID who struggle with breathlessness may have underlying muscle dysfunctions that go undetected in conventional assessments. The team used advanced measures like diaphragm voluntary activation index (DVAI) and transdiaphragmatic pressure to pinpoint these abnormalities, underscoring the need for specialized diagnostics in such cases.
 
Concluding Thoughts
The potential impact of Inspiratory Muscle Training on long COVID-related dyspnea is promising, suggesting a much-needed avenue for those experiencing persistent breathing difficulties. This study provides hope that a non-invasive, exercise-based intervention could offer relief to many people still grappling with long COVID symptoms. As more healthcare providers begin to consider respiratory muscle training for post-COVID-19 conditions, IMT could become a part of standard care for long COVID patients.
 
For those enduring the long-term effects of COVID-19, especially breathlessness without clear lung or cardiac issues, therapies like IMT might offer a breath of fresh air - literally. By improving diaphragm function and endurance, IMT provides a way to target the often-overlooked muscular component of breathing difficulties.
 
The study findings were published in the peer-reviewed American Journal of Respiratory and Critical Care Medicine.
https://www.atsjournals.org/doi/full/10.1164/rccm.202309-1572OC
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/polish-study-finds-that-covid-19-causes-diaphragmatic-dysfunction
 
https://www.thailandmedical.news/news/diaphragm-muscle-atrophy-linked-to-long-term-fatigue-in-covid-19-survivors
 
https://www.thailandmedical.news/news/covid-19-news-post-covid-respiratory-muscle-weakness-and-reduced-exercise-capacity-is-associated-with-reduced-phrenic-nerve-cmap
 
https://www.thailandmedical.news/news/covid-19-news-study-shows-that-sars-cov-2-infections-can-cause-acute-phrenic-neuropathy-and-diaphragmatic-dysfunction
 
https://www.thailandmedical.news/news/even-asymptomatic-and-mild-covid-19-causes-neuromuscular-damage-to-the-diaphragm-resulting-in-the-long-covid-manifestations-of-fatigue-and-dyspnea